Tms paper is concerned with the problem of whether the incidence of malignant diseases in diabetics is significantly different from that in non-diabetics. While the material of autopsies from the Pathology Department of Bristol Universitv and the chnical material from the Bristol Royal Infirmarv confirm the negative association between the two diseases which has been the subject of previous investigations, a critical examination reveals the new fact that such a negative association would seem to applv more to females. It is shown that the explanation of a negative association between mahgnant tumours and diabetes is in agreement with what has emerged so far about a hormonal impfication via the disturbance of the glucose metabohsm in both diseases.
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The results of an examination of post mortem records in the Patholog-N-Department of the Universitv of Bristol are shown in Table 1 . (Herdan, 1955) . Entering the chart with p 10-1 on the upper horizontal scale and projecting the crossing point of the vertical with the curve n 189 to the left (or right), we read there the difference between the upper limit for the population probability p., and p as slightly less than 8, and obtain, therefore, the upper limit p. as slightly less than 18, which is significantly smaller than the observed figure, 19 The justification for such a procedure-which is rather important both from the theoretical and practical angle as will be explained below, can be seen from Table III which gives relevant numbers as in Table I for six investigations of that kind. 1940 1944 1952 1954 1955 1959 We shall consider as a particular case the last of these investigations which does not differ essentially from the others in its results. On the basis of 22,971 P.M. records from the University Clinic of Halle a/S the percentage of malignant cases resulted as 18, remarkably close to the figure for Bristol, 19-2. The percentage of coincidence cases of diabetes and malignant disease was for Halle 8-8 per cent, again remarkably close to the figure for Bristol, 10'1 per cent. The significance test shows that we may regard the basis of the two investigations as one statistical population of P.M.'s in which the percentages of tumours, 18 and 19-2 differ by not more than could be accounted for by random sampling from that one population. The same applies to the percentages of coincidence cases, 8-8 and 1041 per cent.
To counter the possible objection that the negative association between malignant disease and diabetes is only apparent and due to the fact that the diabetic does not live long enough to be attacked by malignant disease, we give below the age distribution of the coincidence cases which shows the coincidence cases as not being different in age distribution from the total of cancer cases.
The same is, by and large, true for the German coincidence cases. Both malignancy and diabetes and also the coincidence cases, increase with age and then decrease again. The peak of the age curve in Germany lies between 55 and 65 years for malignancy and for the diabetics between 61 and 70 years, and for the coincidence cases between 71 and 80 years. This means that today diabetics reach a sufficiently high age to be exposed to the risk of the malignant disease like other parts of the population. According to the literature, the clinical experience did not always seem to bear out the conclusion reached from a study of P.M.'s. Thus, Constam (1950) , who gives the percentage of the incidence of malignant tumours in non-diabetics as 3-0 per cent and among diabetics as 5-1 per cent.
In order to check these findings I obtained from Bristol Royal Hospit'al, Royal Infirmary Branch, the corresponding data for 7 years, 1953-59, which are set out in Table V . The results are most interesting in so far as they seem fully to support the conclusion obtained from our P.M. data. The incidence of malignant tumours among diabetics is considerably less than among all in-patients, the ratio between the two overall percentages, 2-84 and 5-69, being approximately 0-50 which is in good agreement with the ratio of the corresponding percentages obtained from our P.M. data, 10-1 and 19-2, which is 0-53. The percentage of tumours among non-diabetics is 5-75. On the basis of our data, be they from P.M.'s or from clinical experience, we have therefore, no reason to doubt the significantly reduced incidence of malignant tumours among diabetics.
Section 5
Inspection of In words: for males the incidence of malignant tumours in the population of autopsies is 1-15 times that among diabetics, whereas for females the corresponding figure is 2-73 ; or conversely, the occurrence of malignant tumours among diabetic males is 87 per cent of that in the total autopsies population, whereas for females it is only 37 per cent. This means that if the difference in sex distribution is duly taken into account we find that the observed overall negative association between the two diseases is. by and large, true only for the female sex. For males, the incidence of malignant diseases in the total of autopsies is not significantly different from that among diabetic autopsies (1-15 times). Common to both diseases is the pathological change in glucose metabolism. In diabetes the transport of glucose through the cell membrane is slowed up. According to Rockstroh and Schr6ter (1960) , the application of insulin causes glucose to pass at an increased rate through the membrane into the cell, where it is used for the production of energy. On the other hand, in the cancer cell, fermentation of glucose goes through the same enzymatic reaction as in glycolysis, and since the latter is activated by the application of insulin, insulin will increase an existing tumour ; Rockstroh and This is the reverse of the possible influence of diabetes upon the incidence of human tumours which emerges from the P.M. analysis given in Sections I and 2.
